Status:
COMPLETED
Teduglutide in Short Bowel Syndrome Patients
Lead Sponsor:
Medical University of Vienna
Conditions:
Short Bowel Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
A retrospective analysis was performed using data of patients suffering from non-malignant SBS-IF. They were treated with teduglutide in a multidisciplinary SBS-IF program at a single university medic...
Eligibility Criteria
Inclusion
- SBS-IF
Exclusion
- \< 18 years
- Incompliance
- \< 6 months of treatment
Key Trial Info
Start Date :
June 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04857801
Start Date
June 1 2016
End Date
June 1 2020
Last Update
April 26 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.